370 related articles for article (PubMed ID: 29713851)
1. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
Wang X; Zhao Z; Hou Y; Tang E; Zhao G; Wang S; Bi Y; Zhong C; Ren M; Zhang J; Mao J; Zhang B
Cardiovasc Drugs Ther; 2018 Jun; 32(3):295-300. PubMed ID: 29713851
[TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
Trials; 2013 May; 14():138. PubMed ID: 23672353
[TBL] [Abstract][Full Text] [Related]
3. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
Trials; 2015 May; 16():222. PubMed ID: 25994188
[TBL] [Abstract][Full Text] [Related]
4. [Network Meta-analysis of different Chinese medicine injections combined with conventional western medicine in treatment of acute heart failure].
Wang W; Kong FT; Li R; Zhao XK; Li YD; Liu K
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):251-267. PubMed ID: 38403358
[TBL] [Abstract][Full Text] [Related]
5. HPLC-QTOF/MS-based metabolomics to explore the molecular mechanisms of Yiqi Fumai Lyophilized Injection in heart failure mice.
Yuan GY; Liu ZL; Lai Q; Fu F; Zhang L; Kou JP; Yu BY; Li F
J Sep Sci; 2021 Jul; 44(13):2545-2563. PubMed ID: 33942520
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
[TBL] [Abstract][Full Text] [Related]
7. [Network Meta-analysis of efficacy and safety of different traditional Chinese medicine injections in treating post-acute myocardial infarction heart failure].
Sun Y; Qiao LJ; Wei JJ; Li B; Gao Y; Zhu MJ
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(21):5932-5945. PubMed ID: 38114189
[TBL] [Abstract][Full Text] [Related]
8. Qishen Yiqi dripping pills for ischemic heart failure: A protocol for a prospective cohort study.
Zhao Z; Wang X; Hou Y; Wang S; Zhai J; Wang C; Mao J; Zhang B
Medicine (Baltimore); 2018 Nov; 97(45):e13085. PubMed ID: 30407310
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription: study protocol for a randomized controlled trial.
Deng D; Chen Z; Jia L; Bu J; Ye M; Sun L; Gen Y; Zhang W; Chen G; Fang B
Trials; 2019 Dec; 20(1):817. PubMed ID: 31888702
[TBL] [Abstract][Full Text] [Related]
10. Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial.
Wang X; Hu D; Dang S; Huang H; Huang CX; Yuan MJ; Tang YH; Zheng QS; Yin F; Zhang S; Zhang BL; Gao RL;
Chin Med J (Engl); 2017 Jul; 130(14):1639-1647. PubMed ID: 28685712
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
Trials; 2015 Dec; 16():561. PubMed ID: 26654631
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
[TBL] [Abstract][Full Text] [Related]
13. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
Guo L; Yuan H; Zhang D; Zhang J; Hua Q; Ma X; Chen K
Medicine (Baltimore); 2020 May; 99(21):e20271. PubMed ID: 32481305
[TBL] [Abstract][Full Text] [Related]
14. Medicinals with properties of warming Yang and tonifying Qi in terms of Traditional Chinese Medicine: their effects on left ventricular ejection fraction and aldosterone in rats with induced failure heart.
Han L; Wang Z; Chai S; Xing G; Wang H; Yuan B; Li Z; Su S
J Tradit Chin Med; 2016 Dec; 36(6):789-93. PubMed ID: 29949839
[TBL] [Abstract][Full Text] [Related]
15. Research based on the core pathogenesis in the treatment according to traditional Chinese medicine syndrome differentiation for heart failure with normal ejection fraction.
Zhao Z; Wang X; Wang S; Zhou R; Su Q; Liu Y; Cheng T; Li Q; Lin S; Liu H; Mao J
Medicine (Baltimore); 2020 Sep; 99(37):e21663. PubMed ID: 32925713
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Shenfu injection combined with sodium nitroprusside in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
Guo B; Yang T; Nan J; Huang Q; Wang C; Xu W
Medicine (Baltimore); 2021 Feb; 100(7):e24414. PubMed ID: 33607775
[TBL] [Abstract][Full Text] [Related]
17. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
18. Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial.
Choi DJ; Park CS; Park JJ; Lee HY; Kang SM; Yoo BS; Jeon ES; Hong SK; Shin JH; Kim MA; Park DG; Kim EJ; Hong SJ; Kim SY; Kim JJ
Trials; 2018 Feb; 19(1):103. PubMed ID: 29433525
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
Shen L; Ramires F; Martinez F; Bodanese LC; Echeverría LE; Gómez EA; Abraham WT; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Jhund PS; Gimpelewicz CR; McMurray JJV;
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
[TBL] [Abstract][Full Text] [Related]
20. Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial.
Wang Y; Wang X; Wang J; Li B; Yu R; Hu Y; Li X; Peng G; Zhang M; Zhu M
Trials; 2020 Mar; 21(1):287. PubMed ID: 32197640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
